Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 6, No 2 (2013) PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS Abstract  similar documents
A. Yu. Kulikov, V. G. Serpik
"... with Dorzopt and Trusopt from cost-efficacy perspective and can be claimed dominant. Futhermore Azopt ..."
 
Vol 10, No 3 (2017) Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients Abstract  similar documents
N. K. Mazina, P. V. Mazin
"... (after treatment with docetaxel) in the Russian Federation. Materials and Methods. A cost effectiveness ..."
 
Vol 13, No 2 (2020) Affordability of in vivo gene therapy. Problems and potential solutions Abstract  similar documents
V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko
"... for the cost of these four drugs in the European countries showed that there were no special procedures ..."
 
Vol 13, No 3 (2020) The evaluation of the balance of standard rates within the program on state guarantees to deliver free medical care to the citizens of the Russian Federation Abstract  similar documents
D. V. Fedyaev, S. A. Kovaleva, K. V. Gerasimova
"... costs in the subjects of the RF was based on the Decrees of the Government for 2019 and 2020 ..."
 
Vol 13, No 3 (2020) Regulatory framework of the oncological medical care provision Abstract  similar documents
S. N. Tishkina, V. E. Matskevich, Yu. A. Ledovskikh, E. V. Semakova, V. V. Omelyanovskiy
 
Vol 6, No 4 (2013) Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia Abstract  similar documents
R. I. Yagudina, I. Yu. Zinchuk
"... and indirect costs shows that the costs of the annual course of treatment of 142 patients in Russia are 66 mil ..."
 
Vol 13, No 4 (2020) Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia Abstract  similar documents
V. G. Deriushkin, A. P. Ternavskii, S. V. Gatsura
"... endorsed by the Moscow Department of Healthcare (MDH) in 2018. The analysis of the used AMPs costs in real ..."
 
Vol 10, No 2 (2017) PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY Abstract  similar documents
A. V. Rudakova, S. A. Protsenko, I. A. Koroleva
"... are recommended to be used in such clinical situations. The aim of the study was to estimate the costs ..."
 
Vol 9, No 2 (2016) BUDGET IMPACT ANALYSIS OF PERAMPANEL FOR ADJUNCTIVE TREATMENT IN EPILEPSY PATIENTS 12 YEARS OF AGE AND OLDER FOR PARTIAL ONSET SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION AND PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN THE RUSSIAN FEDERATION Abstract  similar documents
V. R. Mkrtchyan, A. M. Sergeev, K. I. Pochigaeva, I. A. Shpak
"... scenarios: Cost of POS & PGTCS without Perampanel and Cost of POS & PGTCS with Perampanel (Perampanel ..."
 
Vol 13, No 2 (2020) Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation Abstract  similar documents
S. V. Malchikova, A. N. Korobeinikova, N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva
"... the medical healthcare system perspective. Methods of clinical-economic analysis: analysis “cost-effectiveness ..."
 
Vol 9, No 3 (2016) COPAYMENTS OF THE CITIZENS IN HEALTHCARE SYSTEM: INTERNATIONAL PRACTICE Abstract  similar documents
A. P. Tatarinov, D. V. Lukyantseva, L. S. Melnikova, V. V. Omelyanovskii
"... The growth of cost of healthcare services becomes more and more serious problem throughout ..."
 
Vol 6, No 3 (2013) METHODOLOGICAL BASIS OF STANDARD GAMBLE METHOD USAGE IN QUALITY OF LIFE ASSESSMENT IN PHARMACOECONOMIC RESEARCHES Abstract  similar documents
R. I. Yagudina, A. Ju. Kulikov, D. T. Ugrekhelidze
 
Vol 7, No 3 (2014) MODELI NG CLINICAL AND ECONOMIC OUTCOMES OF TESTING FOR LTBI WITH T-SPOT.TB IN IMMUNOCOMPROMISED CHILDREN Abstract  similar documents
V. I. Ignatyeva, M. V. Avxentyeva, V. V. Omelyanovsky, G. R. Khachatryan
"... the immunoenzymometric interferon-gamma tests, T-SPOT.TB among them, but their costs are substantially higher than cost ..."
 
Vol 9, No 4 (2016) RESOLUTIONS OF VII RUSSIAN CONGRESS OF PATIENTS Abstract  similar documents
Editorial article
 
Vol 7, No 2 (2014) CLINICAL AND ECONOMIC EVALUATION OF IVABRADINE USE IN STABLE ANGINA IN TERMS OF REPUBLIC OF BELARUS HEALTH CARE SYSTEM Abstract  similar documents
I. N. Kozhanova, I. S. Romanova, L. N. Gavrilenko, A. V. Patseev, M. M. Sachek
"... stable angina is a socially significant disease that requires significant financial costs ..."
 
Vol 11, No 2 (2018) Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia Abstract  similar documents
N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov
"... , dasatinib or bosutinib second-line therapy and calculated the medical costs per patient. Both ..."
 
Vol 6, No 3 (2013) PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER Abstract  similar documents
R. I. Yagudina, I. Yu. Zinchuk
"... , regional relapse and metastasis insignificantly as well. In the result of direct costs analysis ..."
 
Vol 9, No 2 (2016) EVALUATION OF RATIONALITY OF EXPENSES ON TREATMENT OF SEVERE COMMUNITY-ACQUIRES PNEUMONIA IN MULTI-PROFILE HOSPITAL Abstract  similar documents
I. V. Demko, N. V. Gordeeva, E. N. Bochanova, N. I. Golovina, A. Yu. Kraposhina, I. A. Soloveva, E. A. Sobko, T. V. Gaygolnik, S. V. Chubarova
"... about the cost of drug which were received from the database of «1C: Drugstore» of regional clinical ..."
 
Vol 6, No 4 (2013) Pharmacoeconomic analysis of blood glucose meter Contour TS in diabetes treatment Abstract  similar documents
A. U. Kulikov, V. V. Babiy
"... influence on the cost and effectiveness of diabetes and its complications treatment. This pharmacoeconomic ..."
 
Vol 8, No 1 (2015) SOCIAL AND ECONOMIC BURDEN OF FIVE NATURAL FOCAL INFECTIONS IN THE RUSSIAN FEDERATION Abstract  similar documents
A. E. Platonov, N. A. Avksentyev, M. V. Avksentyeva, E. V. Derkach, O. V. Platonova, A. V. Titkov, N. M. Kolyasnikova
"... Study objective: to perform assessment of the social and economic burden (analysis of the cost ..."
 
Vol 8, No 1 (2015) PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION Abstract  similar documents
M. V. Avxentyeva, N. A. Avxentyev, M. Yu. Frolov, E. V. Derkach
"... Objective: to calculate cost difference between two approaches for immunosuppressive therapy after ..."
 
Vol 6, No 4 (2013) Pharmacoeconomic study of nutrition support in the conditions of current health care system in Russia Abstract  similar documents
I. A. Metelkin, R. I. Yagudina
"... costs were taken into account: expenses for drug therapy, hospitalization (intensive care unit ..."
 
Vol 12, No 4 (2019) Evolution of healthcare provider payment mechanisms Abstract  similar documents
V. V. Omelyanovskiy, N. N. Sisigina, V. K. Fedyaeva, N. Z. Musina
"... the societal demands (greater access to health services, cost reduction, and better quality) and prevent “moral ..."
 
Vol 7, No 3 (2014) ECONOMIC JUSTIFICATION FOR TELEHEALTH TECHNOLOGY USE FOR PREVENTIVE MEDICAL EXAMINATION OF THE POPULATION IN REMOTE REGIONS Abstract  similar documents
D. V. Fedyaev, V. K. Fedyaeva, V. V. Omelyanovsky
"... of research show that application of a telemedical complex allows to return costs of its acquisition due less ..."
 
Vol 9, No 2 (2016) PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA Abstract  similar documents
N. A. Avxentyev, M. Yu. Frolov
"... (controlled release tablets 0.4 mg) and solifenacin (5 mg). These options are evaluated with cost minimization ..."
 
Vol 10, No 1 (2017) CLINICAL AND ECONOMIC EVALUATION OF ERIBULIN EFFECTIVENESS IN SOFT TISSUE SARCOMA: RESULTS OF META-ANALYSIS Abstract  similar documents
P. V. Мazin, I. V. Sheshunov, N. K. Mazina, E. M. Markova
"... parameters in this study. The impact on the budget and the “cost-effectiveness” index were also analyzed ..."
 
Vol 6, No 4 (2013) Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital Abstract  similar documents
A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina
"... . This study estimated the cost of illness, probability of development different events in varied strategy ..."
 
Vol 9, No 3 (2016) CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY Abstract  similar documents
E. A. Pyadushkina, M. Yu. Frolov
"... allows calculation of the direct medical costs (for the drugs and medical services) and direct non ..."
 
Vol 9, No 1 (2016) PHARMACOECONOMIC SUBSTANTIATION OF APPLICATION OF GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN OUT-PATIENT CONDITIONS Abstract  similar documents
O. Yu. Korennova, L. V. Shukil', S. N. Mal'tsev, I. A. Klinyshkov, N. M. Leganova, E. A. Turusheva, T. V. Kropotina
"... on a method "cost minimization" was put the actual quantity of patients (57 persons) with RD who had ..."
 
Vol 13, No 3 (2020) The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups Abstract  similar documents
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan
"... of patients that could have been treated without an increase in the costs of compulsory medical insurance (CHI ..."
 
Vol 9, No 3 (2016) HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE Abstract  similar documents
A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina
"... conditions. Markov modelling and CEA accounting for direct medical costs were used. The effectiveness ..."
 
Vol 10, No 2 (2017) PHARMACOECONOMIC EVALUATION OF POMALIDOMIDE (IMNOVID) FOR THE TREATMENT OF RECURRENT AND REFRACTORY MULTIPLE MYELOMA Abstract  similar documents
M. Yu. Frolov, O. V. Shatalova
"... and lenalidomide) line therapy. Materials and Methods. In this study, the methods of cost analysis, cost ..."
 
Vol 12, No 4 (2019) The health technology assessment system in Australia Abstract  similar documents
V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan
"... the product, assessment of its clinical efficacy, cost-effectiveness analysis, assessment of financial ..."
 
Vol 10, No 3 (2017) The strategies of drug supply for patients with chronic hepatitis C Abstract  similar documents
E. V. Kornilova, A. D. Ermolaeva, M. G. Rusanova, D. A. Andreev, M. V. Davydovskaya, T. N. Ermolaeva, A. g Pokatilo, K. I. Polyakova, V. A. Dubovtseva, K. А. Kokushkin, A. V. Devyatkin
"... В статье рассмотрены варианты лекарственного обеспечения пациентов с хроническим вирусным гепатитом ..."
 
Vol 11, No 1 (2018) Modeling microbial drug-resistance: from mathematics to pharmacoeconomics Abstract  similar documents
Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko
"... experience with antimicrobial drugs,  we calculated the cost of treatment of complicated IAI when either ..."
 
Vol 6, No 1 (2013) PHARMACOECONOMIC STUDY OF SKIN TESTS IN THE DIAGNOSTICS OF TUBERCULOSIS INFECTION Abstract  similar documents
R. I. Yagudina, I. Yu. Zinchuk
"... for intradermal use (PPD RT 23 SSI). The «cost-effectiveness» analysis was provided. In the study direct costs ..."
 
Vol 10, No 1 (2017) THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT Abstract  similar documents
V. A. Nevzorova, M. V. Mokshina, T. A. Brodskaya, D. A. Vasil’chenkov, D. V. Blinov, T. I. Ushakova
"... пациентов в России увеличилась за период с 2007 по2015 г. и достигла 37,3%. В данной работе в рамках ..."
 
Vol 11, No 3 (2018) Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review Abstract  similar documents
D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin
"... взрослых пациентов. Материалы и методы. Определены критерии PICo(S): популяция – больные с РРС ..."
 
Vol 11, No 4 (2018) Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease Abstract  similar documents
V. I. Ignatyeva, S. V. Moiseev, N. M. Bulanov, E. A. Karovajkina, A S. Moiseev
"... препаратов ферментозаместительной терапии (ФЗТ) приводит к значительному улучшению исходов для пациентов ..."
 
Vol 12, No 1 (2019) Efficacy of photodynamic therapy in treatment of adult patients with skin cancer Abstract  similar documents
O. V. Kirsanova
"... доказательств эффективности применения ФТД в лечении онкологических заболеваний кожи у пациентов старше 18 лет в ..."
 
Vol 8, No 1 (2015) BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD Abstract  similar documents
A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina
"... первой линии терапии множественной миеломы у пациентов старше 65 лет, которым не показана аутологичная ..."
 
Vol 11, No 1 (2018) Options to optimize the access to biosimilars: analysis and solutions Abstract  similar documents
O. V. Kirsanova, V. V. Omelyanovsky
"... The cost of medical care has been growing around the world; this is due to a number of factors ..."
 
Vol 6, No 1 (2013) THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION Abstract  similar documents
A. Yu. Kulikov, Yu. L. Akimova
"... performed accounts of costs associated with vaccination and also accounts and analysis of performance ..."
 
Vol 11, No 1 (2018) Antimicrobial therapy of community-acquired pneumonia in a hospital setting (clinical and economic aspects) Abstract  similar documents
O. V. Zhukova, O. V. Ruina, M. V. Khazov, S. V. Romanov
"... generation cephalosporins (not part of the standard). The average duration  and cost of monotherapy ..."
 
Vol 8, No 2 (2015) SYSTEMATIC LITERATURE REVIEW ON CLINICAL EFFICACY AND SAFETY OF ALOGLIPTIN IN COMPARISON WITH VILDAGLIPTIN, LINAGLIPTIN, SAXAGLIPTIN AND SITAGLIPTIN IN ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS Abstract  similar documents
Georgii Rubenovich Khachatryan, Vladislav Sergeevich Dombrovskii
"... безопасности алоглиптина у взрослых пациентов с СД2Т в сравнении с другими ингибиторами ДПП-4. Материалы и ..."
 
Vol 8, No 3 (2015) ORGANIZATION AND ANALYSIS OF THE COMMISSION'S WORK ON THE SELECTION AND REFERRAL OF PATIENTS IN A MEDICAL INSTITUTION FOR TREATMENT USING ASSISTED REPRODUCTIVE TECHNOLOGIES ON THE TERRITORY OF THE CHELYABINSK REGION Abstract  similar documents
M. G. Moskvicheva, V. V. Saharova, Yu. A. Semenov, E. V. Orehova
"... здравоохранения Челябинской области работает Комиссия по отбору и направлению пациентов в медицинские организации ..."
 
Vol 7, No 2 (2014) ANALYSIS OF DRUG PRODUCTS ASSORTMENT ACQUIRABLE BY HEALTHCARE ORGANIZATIONS FOR MEDICAL TREATMENT IN HOSPITAL SETTINGS WAS CONDUCTED Abstract  similar documents
M. G. Malaev
"... on acquisition of drug products with proven clinical efficiency and minimal treatment cycle cost. ..."
 
Vol 7, No 2 (2014) ECONOMIC ANALYSIS OF USE OF IMMUNOCORRECTIVE PREPARATIONS FOR PREVENTION OF OFTEN RESPIRATORY INFECTIONS AND THEIR COMPLICATIONS AT CHILDREN OF SCHOOL AGE Abstract  similar documents
R. V. Maiorov, D. P. Derbenev
"... infections and considerable decrease direct and indirect cost on treatment of respiratory infectious diseases ..."
 
Vol 10, No 3 (2017) Evaluation of economic damage from multiple sclerosis in the city of Ufa, Russia Abstract  similar documents
E. V. Ivanova, K. Z. Bachtiyarova
"... ) expenses leads to a sharp increase in indirect costs; this situation necessitates an updated assessment ..."
 
Vol 8, No 2 (2015) CLINICAL AND ECONOMIC ANALYSIS OF THE USE OF DIFFERENT TYPES OF SYSTEMS OF VENOUS ACCESS IN THE TREATMENT OF CHILDREN WITH CANCER Abstract  similar documents
Maksim Yur'evich Rykov, Vladimir Georgievich Polyakov
"... analysis systems venous access in order to optimize the cost of treatment of children with cancer ..."
 
101 - 150 of 188 Items << < 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)